Conatus Pharmaceuticals Announces Two Poster Presentations At EASL Conference
April 22, 2017 at 17:34 PM EDT
Conatus Pharmaceuticals shows two posters at EASL conference that show a decrease in MELD might correlate with longer-term survival in transplant patients.
